Ampio Pharmaceuticals, Inc. (AMPE.OB) Initiates Phase II Clinical Trial of Optina™ for Diabetic Macular Edema
Ampio Pharmaceuticals, Inc., a developer of innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease,…